WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Mitogen Activated Protein Kinase 1 - Pipeline Review, H1 2018”
Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 220.127.116.11) - Mitogen-activated protein kinase 14 also called p38-alpha is an enzyme belongs to p38 MAPK family. p38-alpha MAPK play an important role in the cascades of cellular responses evoked by extracellular stimuli such as proinflammatory cytokines or physical stress leading to direct activation of transcription factors. p38-alpha MAPK is expressed in many cell types. p38-alpha MAPK is implicated in cell apoptosis, proliferation, differentiation, migration, mRNA stability, and inflammatory response in different cell types through variety of different target molecule.
Click here for sample report @ https://www.wiseguyreports.com/sample-request/3031121-mitogen-activated-protein-kinase-1-ert1-or-map
Major Key Players:
Eli Lilly and Co
Kalyra Pharmaceuticals Inc
Kura Oncology Inc
Merck & Co Inc
Mitogen Activated Protein Kinase 1 Industry Major Outlook
Pharmaceutical and Healthcare latest pipeline guide Mitogen Activated Protein Kinase 1 - Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Mitogen Activated Protein Kinase 1 , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.
Mitogen Activated Protein Kinase 1 (ERT1 or MAP Kinase Isoform p42 or Extracellular Signal Regulated Kinase 2 or Mitogen Activated Protein Kinase 2 or MAPK1 or EC 18.104.22.168) targeted therapeutics development with respective active and dormant or discontinued projects. Currently, The molecules developed by companies in Phase II, Phase I, Preclinical and Discovery stages are 2, 4, 1 and 4 respectively.
Mitogen Activated Protein Kinase 1 pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.
Mitogen Activated Protein Kinase 1 - Competitive Analysis
Key players are making innovative developments in Mitogen Activated Protein Kinase 1 industry. The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector
The pipeline guide provides a snapshot of the global therapeutic landscape of Mitogen Activated Protein Kinase 1.
The pipeline guide reviews pipeline therapeutics for Mitogen Activated Protein Kinase 1 by companies and universities/research institutes based on information derived from company and industry-specific sources.
The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
The pipeline guide reviews key companies involved in Mitogen Activated Protein Kinase 1 therapeutics and enlists all their major and minor projects.
The pipeline guide evaluates Mitogen Activated Protein Kinase 1 therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
The pipeline guide reviews latest news related to pipeline therapeutics for Mitogen Activated Protein Kinase 1.
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3031121-mitogen-activated-protein-kinase-1-ert1-or-map
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Partner Relations & Marketing Manager
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)